Capillarisin is primarily studied for its significant biological activities, particularly in the field of pharmacology and natural product research. It exhibits strong anti-inflammatory and antioxidant properties, making it a candidate for development in treatments related to liver diseases, such as hepatitis and non-alcoholic fatty liver disease. It has also shown potential in inhibiting the growth of certain cancer cells, especially in liver and colon cancer models, by inducing apoptosis and suppressing tumor proliferation. Due to its ability to modulate key signaling pathways like NF-κB and MAPK, capillarisin is considered a promising lead compound for anti-cancer and hepatoprotective agents. Additionally, it contributes to bile secretion and liver detoxification processes, supporting its traditional use in herbal medicine for jaundice and other hepatic disorders.